Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve
This call for tenders aims to ensure clinical trial preparedness for Filovirus outbreaks through the establishment of an EU-based reserve of investigational vaccines as a critical preparedness measure, given the sporadic yet… The current deadline is 2 Sep 2026, 16:00 UTC. The listed estimated value is €16,000,000.
What the buyer needs
- This call for tenders aims to ensure clinical trial preparedness for Filovirus outbreaks through the establishment of an EU-based reserve of investigational vaccines as a critical preparedness measure, given the sporadic…
- Specifically, the call aims to establish, pilot and maintain an investigational reserve of Filovirus candidate vaccines against Ebola Sudan (SUDV), Ebola Bundibugyo (BDBV) and/or Marburg (MARV), which – in case of an…
- These provisions will allow for the rapid deployment of candidate vaccines for their later-stage development.
- Tenderers will further have to ensure the rapid deployment of the investigational doses, subject to specific conditions being met (such as the occurrence of an outbreak and the expressed consent of the Contracting…
Procurement signals
- Procedure: HADEA/2026/OP/0019
- Procedure type: Source procedure code 47396220
- Contract type: Services contract (31095498)
- Submission method: Electronic submission
- Published: 3 Jun 2026
Procurement categories
CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.
Programme and geography
Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.
Source-backed details
Original identifiers and classification fields from the EU tender source.
- HADEA/2026/OP/0019
- a41196e2-a5b3-443e-88a5-425ab8f1cc7d-CN
- Source procedure code 47396220
- Services contract (31095498)
- 47352360
- Europe/Brussels
- 2 Sep 2026, 16:00 UTC
- 15 Jul 2026, 07:21 UTC
Full official description
This call for tenders aims to ensure clinical trial preparedness for Filovirus outbreaks through the establishment of an EU-based reserve of investigational vaccines as a critical preparedness measure, given the sporadic yet high-consequence nature of these pathogens. Specifically, the call aims to establish, pilot and maintain an investigational reserve of Filovirus candidate vaccines against Ebola Sudan (SUDV), Ebola Bundibugyo (BDBV) and/or Marburg (MARV), which – in case of an outbreak – could be used to advance their development by embedding them in outbreak-associated clinical trials, facilitated through international agreements and frameworks to support such preparedness. These provisions will allow for the rapid deployment of candidate vaccines for their later-stage development. Tenderers will further have to ensure the rapid deployment of the investigational doses, subject to specific conditions being met (such as the occurrence of an outbreak and the expressed consent of the Contracting Authority).